Both in Pharmaceuticals
Zenas BioPharma vs Generate Biomedicines
Over the past year ZBIO returned −11.2% and GENB returned −16.0%; their daily moves had a correlation of 0.40.
ZBIO −11.2% GENB −16.0%Growth of $1, one year, split-adjusted
| Metric | ZBIO | GENB |
|---|---|---|
| Price | $27.62 | $13.21 |
| Market cap | $1.80B | $1.70B |
| Today | −2.71% | −8.64% |
| 1 month | −2.4% | −3.5% |
| 6 months | +28.1% | — |
| Year to date | −23.9% | — |
| 1 year | −7.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | −11145.6% | −1065.2% |
| P/E (TTM) | — | — |
| Price / sales | 1,800.2× | — |
| Net cash | $346.1M | $452.3M |
| Dividend yield | — | — |
| Volatility (60d) | 55.7% | — |
| Short % of float | 40.2% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).